Basic Information
| RNALocate ID: | RLID:11004178 |
| RNA Symbol: | hsa-miR-760 |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-760 |
| RNA ID: | miRBase:MIMAT0004957 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002712 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01002713 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:11004176 | Exosome | Saliva | 19627513 |
| RLID:11004177 | Exosome | B cell line (Raji)|Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11004179 | Microvesicle | Cerebrospinal fluid | 24797360 |
| RLID-D:11000222 | Exosome | Blood | |
| RLID-D:11000733 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-760 | Uterine corpus endometrial carcinoma | MNDR-E-MI-68883 |
| MNDR | hsa-miR-760 | Lymphoma | MNDR-E-MI-68884 |
| MNDR | hsa-miR-760 | Estrogen-receptor positive breast cancer | MNDR-E-MI-68885 |
| MNDR | hsa-miR-760 | Estrogen-receptor negative breast cancer | MNDR-E-MI-68886 |
| MNDR | hsa-miR-760 | Progesterone-receptor positive breast cancer | MNDR-E-MI-68887 |
| MNDR | hsa-miR-760 | Progesterone-receptor negative breast cancer | MNDR-E-MI-68888 |
| MNDR | hsa-miR-760 | Her2-receptor positive breast cancer | MNDR-E-MI-68889 |
| MNDR | hsa-miR-760 | Breast cancer luminal | MNDR-E-MI-68890 |
| MNDR | hsa-mir-760 | Colorectal carcinoma | MNDR-E-MI-68891 |
| MNDR | hsa-miR-760 | Prostate cancer | MNDR-E-MI-68892 |
| MNDR | hsa-miR-760 | Gastric cancer | MNDR-E-MI-68893 |
| MNDR | hsa-mir-760 | Gastric neoplasms | MNDR-E-MI-68894 |
| MNDR | hsa-miR-760 | Alzheimer disease | MNDR-E-MI-68895 |
| MNDR | hsa-miR-760 | Intracranial aneurysm | MNDR-E-MI-68896 |
| MNDR | hsa-miR-760 | Leukemia | MNDR-E-MI-68897 |
| MNDR | hsa-miR-760 | Huntington disease | MNDR-E-MI-68898 |
| MNDR | hsa-miR-760 | Chorea | MNDR-E-MI-68899 |
| MNDR | hsa-miR-760 | Lung cancer | MNDR-E-MI-68900 |
| MNDR | hsa-mir-760 | Parkinson disease | MNDR-E-MI-68901 |
| MNDR | hsa-miR-760 | Parkinson disease | MNDR-E-MI-68902 |
| MNDR | hsa-miR-760 | Breast cancer | MNDR-E-MI-68903 |
| MNDR | hsa-mir-760 | Breast neoplasms | MNDR-E-MI-68904 |
| MNDR | hsa-mir-760 | Cancer | MNDR-E-MI-68905 |
| MNDR | hsa-miR-760 | Pancreatic cancer | MNDR-E-MI-68906 |
| MNDR | hsa-miR-760 | Melanoma | MNDR-E-MI-68907 |
| MNDR | hsa-miR-760 | Rectum adenocarcinoma | MNDR-E-MI-68908 |
| MNDR | hsa-miR-760 | Colon adenocarcinoma | MNDR-E-MI-68909 |
| MNDR | hsa-miR-760 | Relapsing-remitting multiple sclerosis | MNDR-E-MI-68910 |
| MNDR | hsa-mir-760 | Ovarian cancer | MNDR-E-MI-68911 |
| MNDR | hsa-miR-760 | Carcinoma ductal breast | MNDR-E-MI-68912 |
| MNDR | hsa-miR-760 | Glioblastoma | MNDR-E-MI-68913 |
| MNDR | hsa-miR-760 | Malignant glioma | MNDR-E-MI-68914 |
| MNDR | hsa-miR-760 | Chordoma | MNDR-E-MI-68915 |
| MNDR | hsa-miR-760 | Amyotrophic lateral sclerosis | MNDR-E-MI-68916 |
| MNDR | hsa-miR-760 | Osteosarcoma | MNDR-E-MI-68917 |
| MNDR | hsa-miR-760 | Breast carcinoma | MNDR-E-MI-68918 |
| MNDR | hsa-miR-760 | Lung squamous cell carcinoma | MNDR-E-MI-68919 |
| MNDR | hsa-mir-760 | Non-small cell lung cancer | MNDR-E-MI-68920 |
| MNDR | hsa-miR-760 | Lung adenocarcinoma | MNDR-E-MI-68921 |
| MNDR | hsa-miR-760 | Thyroid carcinoma | MNDR-E-MI-68922 |
| MNDR | hsa-mir-760 | Carcinoma renal cell | MNDR-E-MI-68923 |
| MNDR | hsa-miR-760 | Kidney renal clear cell carcinoma | MNDR-E-MI-68924 |
| MNDR | hsa-miR-760 | Kidney renal papillary cell carcinoma | MNDR-E-MI-68925 |
| MNDR | hsa-miR-760 | Renal clear cell carcinoma | MNDR-E-MI-68926 |
| MNDR | hsa-miR-760 | Biliary tract cancer | MNDR-E-MI-68927 |
| MNDR | hsa-miR-760 | Esophageal cancer | MNDR-E-MI-68928 |
| MNDR | hsa-miR-760 | Lung small cell carcinoma | MNDR-E-MI-68929 |
| MNDR | hsa-miR-760 | Breast invasive carcinoma | MNDR-E-MI-68930 |
| MNDR | hsa-miR-760 | Progressive supranuclear palsy | MNDR-E-MI-68931 |
| MNDR | hsa-miR-760 | Hepatocellular carcinoma | MNDR-E-MI-68932 |
| MNDR | hsa-mir-760 | Hepatocellular carcinoma | MNDR-E-MI-68933 |
| MNDR | hsa-miR-760 | Retinoblastoma | MNDR-E-MI-68934 |
| MNDR | hsa-miR-760 | Hodgkin lymphoma | MNDR-E-MI-68935 |
| MNDR | hsa-miR-760 | Skin cutaneous melanoma | MNDR-E-MI-68936 |
| MNDR | hsa-miR-760 | Skin melanoma | MNDR-E-MI-68937 |
| MNDR | hsa-miR-760 | Colorectal cancer | MNDR-E-MI-68938 |
| MNDR | hsa-mir-760 | Colorectal cancer | MNDR-E-MI-68939 |
| MNDR | hsa-miR-760 | Nasopharynx carcinoma | MNDR-E-MI-68940 |
| MNDR | hsa-miR-760 | Nasopharyngeal cancer | MNDR-E-MI-68941 |
| MNDR | hsa-miR-760 | Breast cancer her3+ negative | MNDR-E-MI-68942 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | CSNK2A1 | Homo sapiens | RR00372940 |
TOP